Current clinical trials
There are a number of ongoing clinical trials on HPV and oropharyngeal cancer. Based on evidence of increased incidence in young men, one such trial conducted by the Sydney Kimmel Comprehensive Cancer Center (No. NCT00897273) has gathered information on HPV infection in the mouths of young men to identify potential risk factors for oropharyngeal cancer.

Research on determining molecular pathways of HPV infection will improve personalized treatment for patients with HPV-associated head and neck cancer. Advances in surgical procedures will minimize pain and discomfort. Currently, the CDC advisory panel has recommended vaccinating boys ages 11 to 12 years with Gardasil.20 A combination of prevention, diagnosis, and treatment will help prevent the increase in HPV-associated oropharyngeal cancer.


Continue Reading

References

1. American Cancer Society. Cancer Facts & Figures 2012. Atlanta: American Cancer Society; 2012.

2. Laborde R.R., Wang V.W., Smith T.M., et al. Transcriptional Profiling by Sequencing of Oropharyngeal Cancer. Mayo Clin Proc. 2012;87(3):226–232.

3. Cleveland J.L., Junger M.L., Saraiya M., et al. The connection between human papillomavirus and oropharyngeal squamous cell carcinomas in the United States: Implications for dentistry. JADA. 2011;142(8):915–924.

4. Gillison M.L., Broutian T., Pickard R.K., et al. Prevalence of oral HPV infection in the United States, 2009-2010. JAMA. 2012;Feb 15;307(7):693–703.

5. Herrero R. Chapter 7: Human Papillomavirus and Cancer of the Upper Aerodigestive Tract. J Natl Cancer Inst Monogr. 2003;31:47–51.

6. D’Souza G., Kreimer A.R., Viscidi R., et al. Case-Control Study of Human Papillomavirus and Oropharyngeal Cancer. N Engl J Med. 2007;356:1944–56.

7. HPV and Cancer. National Cancer Institute at the National Institutes of Health. http://www.cancer.gov/cancertopics/factsheet/Risk/HPV#r1. Accessed May 4 2012

8. Oral HPV infection, HPV-related cancers more common in men [news release]. American Society for Radiation Oncology; January 26, 2012. http://www.eurekalert.org/pub_releases/2012-01/asfr-ohi012412.php. Accessed May 4, 2012.

9. Ang K.K., Harris J., Wheeler R., et al. Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer. N Engl J Med. 2010;363:24–35

10. Yavrouian E.J., Sinha U.K. Recent Advances in Biomarkers and Potential Targeted Therapies in Head and Neck Squamous Cell Carcinoma. ISRN Surgery. 2012; doi:10.5402/2012/715743.

11. Zhou Z., Sturgis E.M., Liu Z., et al. Genetic variants of NOXA and MCL1 modify the risk of HPV16-associated squamous cell carcinoma of the head and neck. BMC Cancer. 2012;12:159.

12. Smith E.M., Rubenstein L.M., Haugen T.H., Pawlita M., Turek L.P. Complex Etiology Underlies Risk and Survival in Head and Neck Cancer Human Papillomavirus, Tobacco, and Alcohol: A case for Multifactor Disease. J Oncol. 2012;doi:10.1155/2012/571862.

13. Beachler D.C., Weber K.M., Margolick J.B., et al. Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults. Cancer Epidemiol Biomarkers Prev. 2012;21(1):122–33.

14. Wang Z., Sturgis E.M., Zhang Y., et al. Combined p53-related genetic variants together with HPV infection increase oral cancer risk. Int J Cancer. 2011;doi: 10.1002/ijc.27335

15. Wang Z., Sturgis E.M., Guo W., et al. Association of Combined p73 and p53 Genetic Variants with Tumor HPV16-Positive Oropharyngeal Cancer. PLoS ONE. 2012;7(4):e35522

16. Lajer C.B., Nielsen F.C., Friis-Hansen L., et al. Different miRNA signatures of oral and pharyngeal squamous cell carcinomas: a prospective translational study. British Journal of Cancer 2011;104:830–840.

17. Schache A.G., Liloglou T., Risk J.M., et al. Evaluation of human papillomavirus diagnostic testing in oropharyngeal squamous cell carcinoma: sensitivity, specificity and prognostic discrimination. Clin Cancer Res. 2011;17(19):6262–71.

18. Moore E.J., Olsen S.M., Laborde R.R., et al. Long-term functional and oncologic results of transoral robotic surgery for oropharyngeal squamous cell carcinoma. Mayo Clin Proc. 2012;87(3):219–25.

19. Schwartz D.L., Garden A.S., Thomas J., et al. Adaptive Radiotherapy for Head-and-Neck Cancer: Initial Clinical Outcomes from a Prospective Trial. Int J Radiat Oncol Biol Phys. 2011;doi:10.1016/j.ijrobp.2011.08.017.

20. Wadman M. Universal HPV vaccination for boys recommended. Nature News Blog; October 25, 2011. http://blogs.nature.com/news/2011/10/universal_hpv_vaccination_for.html. Accessed May 7, 2012